![Christoph Massner](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Christoph Massner
Directeur/Bestuurslid bij Ariceum Therapeutics GmbH
Oorsprong van het eerstegraads netwerk van Christoph Massner
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Earlybird Venture Capital GmbH & Co. KG
![]() Earlybird Venture Capital GmbH & Co. KG Investment ManagersFinance Earlybird Venture Capital GmbH & Co. KG (Earlybird VC) is an independent venture capital firm founded by Hendrik Brandis, Roland Manger, Rolf Mathies, and Christian Nagel in 1997. It is a wholly-owned subsidiary of Earlybird VC Management GmbH & Co. KG. The firm is headquartered in Munich, Germany, with another German office in Berlin, and international office in Istanbul, Turkey.
32
| Subsidiary | Investment Managers | 32 |
Ariceum Therapeutics GmbH
![]() Ariceum Therapeutics GmbH Miscellaneous Commercial ServicesCommercial Services Ariceum Therapeutics GmbH is a German clinical stage radiopharmaceutical company that focuses on the diagnosis and precision treatment of certain neuroendocrine and other aggressive, hard-to-treat cancers. Ariceum Therapeutics is based in Berlin, DE, and has subsidiaries in various locations worldwide. The company's lead targeted systemic radiopharmaceutical product, -satoreotide tetraxetan ("satoreotide"), is an antagonist of the somatostatin type 2 (sstr2) receptor, which is overexpressed in neuroendocrine tumors (NETs) and some aggressive cancers such as small cell lung cancer (SCLC) and Merkel cell carcinoma. Ariceum is also developing a radiolabeled PARP-inhibitor (ATT-001), which is slated to enter the clinic in early 2024. The company was founded in 2021, and Manfred Rüdiger has been the CEO of the company since 2021.
8
| Holding Company | Miscellaneous Commercial Services | 8 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Christoph Massner via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
SANOFI | Pharmaceuticals: Major | Corporate Officer/Principal | |
TIGENIX NV | Medical Specialties | Chief Executive Officer | |
Autonomic Technologies, Inc.
![]() Autonomic Technologies, Inc. Electronic Equipment/InstrumentsElectronic Technology Autonomic Technologies, Inc. develops and commercializes innovative therapies for the treatment of severe headache. Its product, the ATI Neurostimulation System, is used for the treatment of acute pain of cluster headache. The company was founded in 2007 and is headquartered in Redwood City, CA. | Electronic Equipment/Instruments | Director/Board Member | |
GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
Booz Allen Hamilton, Inc.
![]() Booz Allen Hamilton, Inc. Engineering & ConstructionIndustrial Services Booz Allen Hamilton, Inc. engages in the provision of management and technology consulting services. Its services include consulting, analytics, digital solutions, engineering, cyber security, and product. The company was founded by Edwin G. Booz in 1914 and is headquartered in McLean, VA. | Engineering & Construction | Corporate Officer/Principal | |
INSEAD | College/University | Masters Business Admin Masters Business Admin | |
Technische Universität München | College/University | Doctorate Degree Undergraduate Degree | |
Affectis Pharmaceuticals AG
![]() Affectis Pharmaceuticals AG Pharmaceuticals: MajorHealth Technology Affectis Pharmaceuticals AG discovers and develops drugs for the treatment of neurodegenerative and neuroinflammatory diseases. Its products in pipeline include AFC-5128, P2X7 Compounds, AFC-5278 and AFC-08. The company was founded in January 2004 by Florian Holsboer, Wolfgang Wurst and Herbert Stadler and is headquartered in Dortmund, Germany. | Pharmaceuticals: Major | Chief Executive Officer Chairman | |
University of Hamburg | College/University | Masters Business Admin Undergraduate Degree | |
Smithkline Beecham Holdings Corp.
![]() Smithkline Beecham Holdings Corp. Pharmaceuticals: MajorHealth Technology Part of GSK Plc, Smithkline Beecham Holdings Corp. produces and distributes pharmaceutical products and dental healthcare products. The company is based in Wilmington, DE. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Cellerix SA
![]() Cellerix SA Pharmaceuticals: GenericHealth Technology Founded in 2004, Cellerix is a biopharmaceutical company that develops innovative treatments based on cell therapy. Cellerix was founded within the Genetrix Group, group of biotechnology companies specialising in biomedicine. The Genetrix Group began its activities in 2001 at the National Centre for Biotechnology (CNB), which belongs to the Spanish Research Council (CSIC). One of the main objectives of Genetrix is to convert basic research results into therapeutic realities. Cellerix is leading the development of a new generation of medicines using expanded adult stem cells from adipose tissue (eASCs). Development is at a clinically advanced stage and the results from clinical trials in Phase I and II have been very promising. Obtaining these eASCs has big advantages because the process makes use of tissue that is almost always discarded from surgical procedures such as liposuction. eASCs have the capacity to activate physiological repair mechanisms through interaction with affected tissue. This technology represents a revolution in the treatment of some diseases that cannot satisfactorily be cured at present. Cellerix is working actively to adapt this new therapeutic strategy to treat autoimmune diseases such as inflammatory bowel disease. The main goal of the company is to market new tools for treating these diseases, which have a considerable negative impact of the quality of life of the sufferers. Cellerix also researches and develops medicines in other areas such as the development of skin equivalents, which are initially intended for the treatment of hereditary diseases such as epidermolysis bullosa. | Pharmaceuticals: Generic | Director/Board Member Chief Executive Officer | |
MERUS N.V. | Biotechnology | Director/Board Member | |
binx health, inc.
![]() binx health, inc. Information Technology ServicesTechnology Services Binx Health, Inc. develops and provides in vitro point-of-care (POC) testing on diseases such as sexually transmitted infections, neonatal sepsis and hospital acquired infections. Its technology products include in diagnostic and immunoassay platform, rapid POC, and nucleic acid detection technology. The company was founded by John Clarkson in 2005 and is headquartered in Trowbridge, the United Kingdom. | Information Technology Services | Director/Board Member Director/Board Member | |
European Biopharmaceutical Enterprises
![]() European Biopharmaceutical Enterprises BiotechnologyHealth Technology European Biopharmaceutical Enterprises develops biological products. The private company is based in Brussels, Belgium. | Biotechnology | President | |
DailyDeal GmbH
![]() DailyDeal GmbH Internet Software/ServicesTechnology Services DailyDeal GmbH operates online shopping portal. It offers daily deals and coupons on shopping, events, hotel, restaurant, wellness, beauty and sport. The firm operates through its offices in Germany, Austria and Switzerland. The company was founded by Fabian Heilemann and Ferry Heilemann in 2009 and is headquartered in Berlin, Germany. | Internet Software/Services | Chief Executive Officer Founder | |
Thermocore Medical Ltd. | Founder | ||
LSP Services Deutschland GmbH | Investment Managers | Private Equity Investor President | |
JenaValve Technology, Inc.
![]() JenaValve Technology, Inc. Medical SpecialtiesHealth Technology JenaValve Technology, Inc. designs, develops, manufactures, and markets transcatheter aortic valve replacement systems. The company was founded on March 27, 2006 and is headquartered in Wilmington, DE. | Medical Specialties | Director/Board Member | |
Alliance for Regenerative Medicine
![]() Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Medical/Nursing Services | Director/Board Member | |
Cryotherapeutics SA
![]() Cryotherapeutics SA Medical SpecialtiesHealth Technology Cryotherapeutics SA develops and markets a cryotherapy system, with focus on highlighting the safety and efficacy of cryoneergy in the cardiovascular system. The firm specializes in the design of a proprietary system to be used in the treatment of coronary artery diseases that cause heart attacks. Its focus areas encompass technology research, system development, and early-stage product commercialization. The company was founded by Randell L. Werneth, John Yianni and Maurice Buchbinder on September 8, 2009 and is headquartered in Cologne, Germany. | Medical Specialties | Director/Board Member Chief Executive Officer | |
Medlumics SL
![]() Medlumics SL Medical SpecialtiesHealth Technology Medlumics SL provides medical imaging diagnostics services. It specializes in optically guided medical devices. The firm’s proprietary integrated optics platform technology combines optical and electrical components in a miniature chip, enabling for the first time complex multi view optical probes of the size of a grain of rice and ultra-portable, hand-held OCT systems that produces real-time images. The company was founded by Eduardo Margallo Balbás and Jose Luis Rubio Guivernau on April 3, 2009 and is headquartered in Tres Cantos, Spain. | Medical Specialties | Director/Board Member | |
Earlybird VC Management GmbH & Co. KG
![]() Earlybird VC Management GmbH & Co. KG Investment ManagersFinance Earlybird VC Management GmbH & Co. KG operates as a alternative investment manager. The company is headquartered in Munich, Germany. | Investment Managers | Founder Founder Founder Chief Executive Officer | |
Alliance for Advanced Therapies
![]() Alliance for Advanced Therapies Medical/Nursing ServicesHealth Services The Alliance for Advanced Therapies’ mission is to improve the legislative, business and science climate for advanced therapies innovation in Europe. In order to do so, AAT promotes the interests of its members and the advanced therapies sector in Europe. AAT coordinates input to, and exchanges information with relevant European authorities. The Alliance also increases awareness of the sector among all relevant stakeholders, with a special focus on investors. Furthermore, AAT promotes increased funding for the sector from public and private sources. | Medical/Nursing Services | Chairman | |
HighLife SAS
![]() HighLife SAS Medical SpecialtiesHealth Technology HighLife SAS develops percutaneous mitral valve replacement therapies. It offers a minimally invasive prosthetic mitral valve that is implanted on a beating heart, while preserving the native valve structure and respecting the surrounding anatomy. The company was founded by Georg Börtle in 2010 and is headquartered in Paris, France. | Medical Specialties | Director/Board Member | |
OncoDNA SA
![]() OncoDNA SA Medical/Nursing ServicesHealth Services OncoDNA SA develops and provides diagnostic and analytical tools for cancer treatment. The firm offers treatment options, integrated biological review, monitoring, pathology and DNA sequencing. The company was founded by Jean-Pol Detiffe on November 29, 2012 and is headquartered in Gosselies, Belgium. | Medical/Nursing Services | Chief Executive Officer | |
Sky & Sand GmbH
![]() Sky & Sand GmbH MiscellaneousMiscellaneous Sky & Sand GmbH operates as a holding company through its subsidiaries operates online portals. The company was founded by Ferry Heilemann and Fabian Heilemann in February 2013 and is headquartered in Berlin, Germany. | Miscellaneous | Chief Executive Officer Chief Executive Officer | |
Institut Für Medizinische Mikrobiologie | College/University | Doctorate Degree | |
TME PHARMA N.V. | Biotechnology | Director/Board Member | |
Tigenix SAU
![]() Tigenix SAU Medical SpecialtiesHealth Technology Part of TiGenix NV, Tigenix SAU is a Spanish company that collects all the research and development of health, agri-food and industrial products from its partners. The company is based in Tres Cantos, Spain. The company has been driving biotechnology in Spain since 1999 and have more than 300 associated companies, startups, and entities. The group Zendal, a 100%% Spanish biopharmaceutical group, includes seven companies focused on manufacturing and commercializing high-value biotechnology products. Tigenix SAU is a member of AseBio, and the membership fees vary depending on the type of entity and the company's age, annual turnover, and equity. The company offers discounts and economic advantages to their members. The AseBio Investor Day is an investment forum that aims to connect the Spanish biotechnology industry with investors. | Medical Specialties | Chief Executive Officer | |
Earlybird Health Management GmbH & Co. KG
![]() Earlybird Health Management GmbH & Co. KG Investment ManagersFinance Earlybird Health Management GmbH & Co. KG engages in the acquisition, management, and sale of participations in companies that specialize in the field of health technology with high growth and value enhancement potential. It also provides consulting services. The company was founded on June 16, 2014 and is headquartered in Cologne, Germany. | Investment Managers | Chief Executive Officer Chief Executive Officer Chief Executive Officer | |
Forto GmbH
![]() Forto GmbH Air Freight/CouriersTransportation Forto GmbH provides freight forwarding and digital interface logistics services through online. The company was founded by Erik Muttersbach, Ferry Heilemann and Michael Wax and is headquartered in Berlin, Germany. | Air Freight/Couriers | Founder Chief Executive Officer | |
Atlantic Therapeutics Ltd.
![]() Atlantic Therapeutics Ltd. Medical SpecialtiesHealth Technology Atlantic Therapeutics Ltd. is a medical device developer of non-invasive pelvic floor strengthening and nerve stimulation products. The firm offers INNOVO products. The company is headquartered in Galway, Ireland. | Medical Specialties | Director/Board Member Director/Board Member | |
Vivet Therapeutics SAS
![]() Vivet Therapeutics SAS BiotechnologyHealth Technology Vivet Therapeutics SAS develops novel gene therapy treatments for inherited metabolic diseases. The firm offers its services under the categorizers of Biopharma, Biotechnology and Health Care. The company was founded by Jean-Philippe Combal, Gloria Gonzalez-Aseguinolaza and Jens Kurth on July 26, 2016 and is headquartered in Paris, France. | Biotechnology | Director/Board Member | |
iQone Healthcare Holding
![]() iQone Healthcare Holding Pharmaceuticals: MajorHealth Technology Part of Triley Bidco Ltd., iQone Healthcare Holding provides pharmaceutical services. The company is based in Geneva, Switzerland. The Swiss company was founded in 1979. iQone Healthcare Holding was acquired by Clinigen Ltd., part of Triley Bidco Ltd. from April 04, 2022 on October 09, 2018 for $8.68 million. | Pharmaceuticals: Major | Director/Board Member | |
Binx Health Ltd.
![]() Binx Health Ltd. Miscellaneous Commercial ServicesCommercial Services Part of binx health, inc., Binx Health Ltd. is a British company that engages in research and development on biotechnology. The company is based in Trowbridge, UK. The company was founded in 2005. The CEO is Jeffrey R. Luber. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Earlybird 2007 Opportunities GmbH & Co. KG
![]() Earlybird 2007 Opportunities GmbH & Co. KG Financial ConglomeratesFinance Earlybird 2007 Opportunities GmbH & Co. KG provides investment services. The private company is based in Munich, Germany. The CEOs are Roland Manger, Rolf Mathies, Christian G. Nagel. The German company was founded in 2014. | Financial Conglomerates | Chief Executive Officer Chief Executive Officer Chief Executive Officer | |
Arvelle Therapeutics International GmbH
![]() Arvelle Therapeutics International GmbH BiotechnologyHealth Technology Arvelle Therapeutics GmbH provides treatment for patients suffering form CNS disorders. The company was founded by Ilise Lombrado, Gregory Mark Weinhoff and Mark Altmeyer and is headquartered in Basel, Switzerland. | Biotechnology | Director-Back Office Operation | |
T-Knife GmbH
![]() T-Knife GmbH BiotechnologyHealth Technology T-Knife GmbH operates as an next-generation adoptive T-cell company using its proprietary humanized T-cell receptor mouse platform to treat solid tumors. The company was founded by Thomas Blankenstein, Elisa Kieback and Holger Specht in 2018 and is headquartered in Berlin, Germany. | Biotechnology | Director/Board Member | |
Earlybird Growth Opportunities Fund I GmbH & Co. KG
![]() Earlybird Growth Opportunities Fund I GmbH & Co. KG Financial ConglomeratesFinance Earlybird Growth Opportunities Fund I GmbH & Co. KG is an investment fund based in Munich, Germany. The CEOs of the German company are Hendrik Brandis, Heiko Thiel. | Financial Conglomerates | Chief Executive Officer Director/Board Member Chief Executive Officer | |
MINERALYS THERAPEUTICS, INC. | Biotechnology | Director/Board Member |
Statistieken
Internationaal
Duitsland | 17 |
Verenigde Staten | 11 |
Frankrijk | 6 |
Verenigd Koninkrijk | 6 |
België | 5 |
Sectoraal
Health Technology | 26 |
Finance | 7 |
Consumer Services | 5 |
Commercial Services | 4 |
Health Services | 4 |
Operationeel
Director/Board Member | 152 |
Chief Executive Officer | 45 |
Private Equity Investor | 38 |
Corporate Officer/Principal | 30 |
Founder | 18 |
Sterkste connecties
Insiders | |
---|---|
Per Anders Göte Samuelsson | 36 |
Lionel Carnot | 27 |
Joachim Rothe | 22 |
Manfred Rüdiger | 22 |
Olivier Litzka | 21 |
Martin C. Münchbach | 20 |
Eduardo Bravo Fernández de Araoz | 19 |
Roland Manger | 19 |
Luca Rancilio | 17 |
Gregor von dem Knesebeck | 13 |
Hendrik Brandis | 12 |
Thom E. Rasche | 10 |
Rainer Christine | 8 |
Rolf Mathies | 8 |
Christian Nagel | 7 |
- Beurs
- Insiders
- Christoph Massner
- Bedrijfsconnecties